Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Amortization - Intangibles: 2023-2024

Historic Amortization - Intangibles for Prime Medicine (PRME) over the last 2 years, with Dec 2024 value amounting to $3.5 million.

  • Prime Medicine's Amortization - Intangibles fell 15.03% to $752,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 55.47%. This contributed to the annual value of $3.5 million for FY2024, which is 38.22% down from last year.
  • Per Prime Medicine's latest filing, its Amortization - Intangibles stood at $3.5 million for FY2024, which was down 38.22% from $5.7 million recorded in FY2023.
  • Prime Medicine's 5-year Amortization - Intangibles high stood at $5.7 million for FY2023, and its period low was $3.5 million during FY2024.
  • Over the past 2 years, Prime Medicine's median Amortization - Intangibles value was $4.6 million (recorded in 2023), while the average stood at $4.6 million.
  • Data for Prime Medicine's Amortization - Intangibles shows a maximum YoY plummeted of 38.22% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Prime Medicine's Amortization - Intangibles stood at $5.7 million in 2023, then crashed by 38.22% to $3.5 million in 2024.